Ipca gets first approval for HCQ in diabetes

India has approved the use of hydroxychloroquine (HCQ) in Type 2 diabetes - potentially the first such clearance for the product.

India has approved the use of hydroxychloroquine (HCQ) in Type 2 diabetes - potentially the first such clearance for the product.

Innovator Sanofi's Plaquenil (hydroxychloroquine sulfate) is currently indicated for the treatment of rheumatoid arthritis, lupus disease and malaria, though Plaquenil...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category